The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation
- 14 November 1975
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 34 (1), 181-187
- https://doi.org/10.1016/0014-2999(75)90238-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- ACCUMULATION AND DISAPPEARANCE OF NORADRENALINE AND ITS MAJOR METABOLITES SYNTHESIZED FROM INTRAVENTRICULARLY INJECTED [3H]DOPAMINE IN THE RAT BRAINJournal of Neurochemistry, 1974
- Identification of free and conjugated 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain by gas chromatography and mass fragmentographyAnalytical Biochemistry, 1973
- A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitorsBritish Journal of Pharmacology, 1972
- Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme typeBritish Journal of Pharmacology, 1971
- Evidence for a specific monoamine oxidase associated with sympathetic nervesNeuropharmacology, 1971
- Separation, detection and quantitative, analysis of urinary β-phenylethylamineJournal of Chromatography A, 1971
- OCCURRENCE AND PROPERTIES OF MONOAMINE OXIDASE IN ADRENERGIC NEURONSJournal of Neurochemistry, 1971
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- The effect of β-phenylethylamine on central and peripheral monoamine-containing neuronsEuropean Journal of Pharmacology, 1967
- DOPA AND OTHER NATURALLY OCCURRING SUBSTANCES AS CAUSES OF STEREOTYPY AND RAGE IN RATSActa Psychiatrica Scandinavica, 1966